Brief: Ocean Biomedical Announces New Glioblastoma Results
27/04/2023 14:27
April 27 (Reuters) - Ocean Biomedical Inc OCEA.O :
* OCEAN BIOMEDICAL (NASDAQ: OCEA) ANNOUNCES NEW GLIOBLASTOMA
RESULTS VALIDATING PROFOUND TUMOR SUPPRESSION WITH ANTI-CHI3L1
ANTIBODY
Source text for Eikon: ID:nGNX3F7Nxz
Further company coverage: OCEA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ocean Biomedical
See all newsTrump's shipbuilding plan could upend ocean cargo industry, companies warn
Brief: Ocean Biomedical Announces Breakthrough Findings In EGFR-Mutant Lung Cancer
Brief: Ocean Biomedical Announces Receipt Of Notice From Nasdaq Regarding Late Filing Of Quarterly Report On Form 10-Q
Brief: Ocean Biomedical receives Nasdaq staff determination letter
Brief: Ocean Biomedical- Ratified Fully Countersigned Copy Of Revised Agreement With Virion Therapeutics Received On Sept 26